195 related articles for article (PubMed ID: 19563647)
1. High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India.
D'souza DT; Mistry NF; Vira TS; Dholakia Y; Hoffner S; Pasvol G; Nicol M; Wilkinson RJ
BMC Public Health; 2009 Jun; 9():211. PubMed ID: 19563647
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of multi drug resistant tuberculosis in people living with HIV in Western India.
Saldanha N; Runwal K; Ghanekar C; Gaikwad S; Sane S; Pujari S
BMC Infect Dis; 2019 May; 19(1):391. PubMed ID: 31068153
[TBL] [Abstract][Full Text] [Related]
3. Effect of a comprehensive programme to provide universal access to care for sputum-smear-positive multidrug-resistant tuberculosis in China: a before-and-after study.
Li R; Ruan Y; Sun Q; Wang X; Chen M; Zhang H; Zhao Y; Zhao J; Chen C; Xu C; Su W; Pang Y; Cheng J; Chi J; Wang Q; Fu Y; Huan S; Wang L; Wang Y; Chin DP
Lancet Glob Health; 2015 Apr; 3(4):e217-28. PubMed ID: 25794675
[TBL] [Abstract][Full Text] [Related]
4. Multidrug-resistant TB among previously treated TB cases: A retrospective study in Nagpur, India.
Munje R; Deshmukh R; Tumane K
Indian J Tuberc; 2015 Oct; 62(4):207-10. PubMed ID: 26970460
[TBL] [Abstract][Full Text] [Related]
5. Initial drug resistance pattern among pulmonary tuberculosis patients.
Gupta H; Kant S; Jain A; Natu SM; Ahluwalia S
Indian J Tuberc; 2013 Jul; 60(3):154-61. PubMed ID: 24000493
[TBL] [Abstract][Full Text] [Related]
6. Alarming levels of drug-resistant tuberculosis in HIV-infected patients in metropolitan Mumbai, India.
Isaakidis P; Das M; Kumar AM; Peskett C; Khetarpal M; Bamne A; Adsul B; Manglani M; Sachdeva KS; Parmar M; Kanchar A; Rewari BB; Deshpande A; Rodrigues C; Shetty A; Rebello L; Saranchuk P
PLoS One; 2014; 9(10):e110461. PubMed ID: 25333696
[TBL] [Abstract][Full Text] [Related]
7. Active case finding of rifampicin sensitive and resistant TB among household contacts of drug resistant TB patients in Andhra Pradesh and Telangana states of India - A systematic screening intervention.
Chatla C; Jaju J; Achanta S; Samyuktha R; Chakramahanti S; Purad C; Chepuri R; Nair SA; Parmar M
Indian J Tuberc; 2018 Jul; 65(3):218-224. PubMed ID: 29933863
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance mutations and heteroresistance detected using the GenoType MTBDRplus assay and their implication for treatment outcomes in patients from Mumbai, India.
Tolani MP; D'souza DT; Mistry NF
BMC Infect Dis; 2012 Jan; 12():9. PubMed ID: 22260344
[TBL] [Abstract][Full Text] [Related]
9. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
10. First and second line drug resistance among treatment naïve pulmonary tuberculosis patients in a district under Revised National Tuberculosis Control Programme (RNTCP) in New Delhi.
Myneedu VP; Singhal R; Khayyam KU; Sharma PP; Bhalla M; Behera D; Sarin R
J Epidemiol Glob Health; 2015 Dec; 5(4):365-73. PubMed ID: 25944154
[TBL] [Abstract][Full Text] [Related]
11. Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?
Dave P; Vadera B; Kumar AM; Chinnakali P; Modi B; Solanki R; Patel P; Patel P; Pujara K; Nimavat P; Shah A; Bharaswadkar S; Rade K; Parmar M; Nair SA
PLoS One; 2015; 10(4):e0121996. PubMed ID: 25874545
[TBL] [Abstract][Full Text] [Related]
12. High degree of fluoroquinolone resistance among pulmonary tuberculosis patients in New Delhi, India.
Sharma R; Sharma SK; Singh BK; Mittal A; Kumar P
Indian J Med Res; 2019 Jan; 149(1):62-66. PubMed ID: 31115377
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for new pulmonary tuberculosis patients failing treatment under the Revised National Tuberculosis Control Programme, India.
Singla R; Srinath D; Gupta S; Visalakshi P; Khalid UK; Singla N; Gupta UA; Bharty SK; Behera D
Int J Tuberc Lung Dis; 2009 Apr; 13(4):521-6. PubMed ID: 19335960
[TBL] [Abstract][Full Text] [Related]
14. Low prevalence of MDR-TB in Lao PDR: results from the first national anti-tuberculosis drug resistance survey.
Iem V; Dean A; Zignol M; Vongvichit P; Inthavong D; Siphanthong S; Sorsavanh T; Kim SJ; Shin S; Sébert J; Chittamany P
Trop Med Int Health; 2019 Apr; 24(4):421-431. PubMed ID: 30663180
[TBL] [Abstract][Full Text] [Related]
15. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
[TBL] [Abstract][Full Text] [Related]
16. Drug resistance to the first line of antitubercular regimen (a preliminary report).
Varaiya A; Gogate A
Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
[TBL] [Abstract][Full Text] [Related]
17. Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.
Parmar MM; Sachdeva KS; Dewan PK; Rade K; Nair SA; Pant R; Khaparde SD
PLoS One; 2018; 13(4):e0193903. PubMed ID: 29641576
[TBL] [Abstract][Full Text] [Related]
18. Trends of anti-tuberculosis drug resistance pattern in new cases and previously treated cases of extrapulmonary tuberculosis cases in referral hospitals in northern India.
Maurya AK; Kant S; Nag VL; Kushwaha RA; Dhole TN
J Postgrad Med; 2012; 58(3):185-9. PubMed ID: 23023350
[TBL] [Abstract][Full Text] [Related]
19. Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment.
Coronel J; Roper MH; Herrera C; Bonilla C; Jave O; Gianella C; Sabogal I; Huancaré V; Leo E; Tyas A; Mendoza-Ticona A; Caviedes L; Moore DA
Clin Microbiol Infect; 2014 Jun; 20(6):536-41. PubMed ID: 24107197
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of multidrug-resistant tuberculosis among newly diagnosed cases of sputum-positive pulmonary tuberculosis.
Sharma SK; Kaushik G; Jha B; George N; Arora SK; Gupta D; Singh U; Hanif M; Vashisht RP
Indian J Med Res; 2011 Mar; 133(3):308-11. PubMed ID: 21441685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
